Cilostazol Eliminates Adverse Smoking Outcome in Patients With Drug-Eluting Stent Implantation:– Analysis of Longer-Term Follow-up of the CILON-T Randomized Trial –
スポンサーリンク
概要
- 論文の詳細を見る
Background: The present study investigated whether cilostazol can eliminate adverse smoking outcome after percutaneous coronary intervention (PCI). Methods and Results: A total of 914 patients with successful drug-eluting stent (DES) implantation were randomly assigned to dual antiplatelet therapy (DAT; aspirin and clopidogrel, n=457) or to triple antiplatelet therapy (TAT; DAT with cilostazol, n=457). The effect of smoking on 2-year major adverse cardio/cerebrovascular events (MACCE) in both the TAT and DAT groups was evaluated. Total MACCE were not significantly different between the 2 anti-platelet regimens (9.8% in TAT vs. 11.4% in DAT groups, P=0.45), but the adverse effects of smoking on clinical outcome were different between DAT vs. TAT. Current smokers had a higher prevalence of MACCE than non-smokers in the DAT group (16.7% vs. 9.5%, P=0.04). In the TAT group, however, the adverse effect of smoking was abolished (9.2% vs. 10.1%, P=0.85). Regarding the effects of smoking on the antiplatelet effects of DAT or TAT, post-treatment platelet reactivity (in P2Y12 reaction units; PRU) in current smokers was not significantly lower than that in non-smokers in the DAT group, whereas, in the TAT group, it was significantly lower than that of non-smokers (189±88 vs. 216±89 PRU, P=0.01). Conclusions: Adverse clinical effects of smoking may be eliminated by the addition of cilostazol to DAT after DES implantation. This may be due to the stimulation of cilostazol's antiplatelet effects by smoking.
- 一般社団法人 日本循環器学会の論文
一般社団法人 日本循環器学会 | 論文
- Evidence for Brain Activation in Patients With Takotsubo Cardiomyopathy
- Impact of Physical Activity on Cardiovascular Events in Patients With Chronic Heart Failure:– A Multicenter Prospective Cohort Study –
- Angioscopic Assessment of Peri-Stent Contrast Staining Following Drug-Eluting Stent Implantation
- Relationships of Elevated Systemic Pentraxin-3 Levels With High-Risk Coronary Plaque Components and Impaired Myocardial Perfusion After Percutaneous Coronary Intervention in Patients With ST-Elevation Acute Myocardial Infarction
- Efficacy of Percutaneous Balloon Aortic Valvuloplasty Visualized on Computed Tomography